High Tide and its U.S. hemp-derived CBD subsidiary, NuLeaf Naturals, have joined the National Compassionate Care Council (NCCC) as founding members.
"Federal cannabis policy in the United States is entering a meaningful transition," said Raj Grover, Founder and Chief Executive Officer of High Tide. "Through our experience building health-focused brands such as NuLeaf Naturals and FAB CBD, we have developed meaningful expertise in serving consumers seeking cannabinoid-based wellness products within a responsible regulatory framework. We are pleased to join the NCCC so that High Tide and NuLeaf can help contribute to the development of thoughtful U.S. federal and state medical cannabis policy, while supporting efforts aimed at improving patient access to cannabinoid therapies across the United States," added Mr. Grover.
The NCCC is dedicated to improving patient access to cannabinoid therapies by modernizing healthcare standards and advancing evidence-based policy. The Council brings together healthcare-focused organizations across the medicinal cannabis sector that prioritize product quality, research, and patient outcomes.
In addition to High Tide and its subsidiaries NuLeaf Naturals and FAB CBD, founding members include Feals, Medterra CBD LLC, Tilray Inc., Realm of Caring, Lazarus Naturals, Constance CBD, and Equilibria.
Recent federal initiatives to reschedule cannabis and explore Medicare reimbursement for hemp-derived cannabinoid products signal a potential shift in U.S. healthcare policy that can have a material impact for High Tide's U.S. based hemp-derived CBD subsidiaries. Through its participation in the NCCC, High Tide aims to contribute industry expertise while supporting broader efforts to expand patient access to safe and effective cannabinoid therapies.
For more information:
High Tide
[email protected]
hightideinc.com
